SCHEMBL2396742

SCHEMBL2396742

CCCCCC/C=C\CCCCCCCC(=O)OCC(C)C

nearest known ligand 0.73

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.73
PRKCE Q02156 1/20 0.69
PRKCQ Q04759 1/20 0.69
PRKCD Q05655 1/20 0.69
PRKCA P17252 1/20 0.69
MAPT P10636 1/20 0.65
LPAR1 Q92633 7/20 0.64
ENPP2 Q13822 4/20 0.64
LPAR3 Q9UBY5 4/20 0.64
LPAR4 Q99677 3/20 0.64
LPAR2 Q9HBW0 3/20 0.64
LPAR5 Q9H1C0 2/20 0.64
CES2 O00748 1/20 0.64
LPAR6 P43657 1/20 0.64
TRPV1 Q8NER1 1/20 0.64
RECQL P46063 1/20 0.61
BLM P54132 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
FAAH O00519 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10655052 1.00 DGKA (0.73) DGKAPRKCEPRKCQPRKCDPRKCA
SCHEMBL2396746 1.00 DGKA (0.73) DGKAPRKCEPRKCQPRKCDPRKCA
SCHEMBL9169289 1.00 DGKA (0.73) DGKAPRKCEPRKCQPRKCDPRKCA
SCHEMBL12438334 1.00 DGKA (0.73) DGKAPRKCEPRKCQPRKCDPRKCA
SCHEMBL9169298 1.00 DGKA (0.73) DGKAPRKCEPRKCQPRKCDPRKCA
SCHEMBL10655057 1.00 DGKA (0.73) DGKAPRKCEPRKCQPRKCDPRKCA
SCHEMBL3658169 1.00 DGKA (0.73) DGKAPRKCEPRKCQPRKCDPRKCA
SCHEMBL332985 1.00 DGKA (0.73) DGKAPRKCEPRKCQPRKCDPRKCA
SCHEMBL332986 1.00 DGKA (0.73) DGKAPRKCEPRKCQPRKCDPRKCA
Ammonia Solution, Strong SCHEMBL8661319 0.98 DGKA (0.71) DGKAPRKCEPRKCQPRKCDPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117924997-A Special printing ink capable of printing embroidery or water drop effect on paper surface 厦门创业人环保科技股份有限公司 2024-04-26 CN claimed
US-9650341-B2 Process for synthesizing oxidized lactam compounds ALKERMES PHARMA IRELAND LIMITED (IE) 2017-05-16 US disclosed
US-8536328-B2 Process for synthesizing oxidized lactam compounds ALKERMES PHARMA IRELAND LIMITED (IE) 2013-09-17 US disclosed
US-8366819-B2 Oily inkjet ink RISO KAGAKU CORPORATION (JP) 2013-02-05 US disclosed
US-20110275803-A1 PROCESS FOR SYNTHESIZING OXIDIZED LACTAM COMPOUNDS ALKERMES, INC. (US) 2011-11-10 US disclosed
US-20110232528-A1 OILY INKJET INK RISO KAGAKU CORPORATION (JP) 2011-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275803-A1 PROCESS FOR SYNTHESIZING OXIDIZED LACTAM COMPOUNDS COASY, DHPS, OXA1L DGKA 2661/4885PRKCE 2537/4885PRKCQ 2469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.